DAVIDE CAMPARI-MILANO NV (CPR.MI) Stock Fundamental Analysis
Europe - BIT:CPR - NL0015435975 - Common Stock
5.958 EUR
+0.07 (+1.19%)
CPR gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 27 industry peers in the Beverages industry. CPR has only an average score on both its financial health and profitability. CPR is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
CPR had positive earnings in the past year.
In the past year CPR had a positive cash flow from operations.
Each year in the past 5 years CPR has been profitable.
CPR had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
CPR has a Return On Assets of 2.38%. This is comparable to the rest of the industry: CPR outperforms 44.44% of its industry peers.
With a Return On Equity value of 5.23%, CPR is not doing good in the industry: 62.96% of the companies in the same industry are doing better.
CPR has a Return On Invested Capital (6.63%) which is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for CPR is in line with the industry average of 7.77%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.38% | ||
| ROE | 5.23% | ||
| ROIC | 6.63% |
ROA(3y)4.29%
ROA(5y)4.52%
ROE(3y)9.66%
ROE(5y)10.08%
ROIC(3y)7.66%
ROIC(5y)7.27%
1.3 Margins
With a Profit Margin value of 6.57%, CPR perfoms like the industry average, outperforming 48.15% of the companies in the same industry.
CPR's Profit Margin has declined in the last couple of years.
CPR's Operating Margin of 21.32% is fine compared to the rest of the industry. CPR outperforms 62.96% of its industry peers.
In the last couple of years the Operating Margin of CPR has remained more or less at the same level.
CPR's Gross Margin of 57.55% is fine compared to the rest of the industry. CPR outperforms 74.07% of its industry peers.
CPR's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 21.32% | ||
| PM (TTM) | 6.57% | ||
| GM | 57.55% |
OM growth 3Y3.05%
OM growth 5Y-0.43%
PM growth 3Y-20.58%
PM growth 5Y-17.07%
GM growth 3Y-1.21%
GM growth 5Y-1.11%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CPR is still creating some value.
The number of shares outstanding for CPR has been increased compared to 1 year ago.
The number of shares outstanding for CPR has been increased compared to 5 years ago.
Compared to 1 year ago, CPR has about the same debt to assets ratio.
2.2 Solvency
CPR has an Altman-Z score of 2.43. This is not the best score and indicates that CPR is in the grey zone with still only limited risk for bankruptcy at the moment.
CPR's Altman-Z score of 2.43 is fine compared to the rest of the industry. CPR outperforms 70.37% of its industry peers.
CPR has a debt to FCF ratio of 13.61. This is a negative value and a sign of low solvency as CPR would need 13.61 years to pay back of all of its debts.
CPR has a Debt to FCF ratio of 13.61. This is in the lower half of the industry: CPR underperforms 70.37% of its industry peers.
CPR has a Debt/Equity ratio of 0.66. This is a neutral value indicating CPR is somewhat dependend on debt financing.
The Debt to Equity ratio of CPR (0.66) is better than 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.66 | ||
| Debt/FCF | 13.61 | ||
| Altman-Z | 2.43 |
ROIC/WACC0.98
WACC6.77%
2.3 Liquidity
CPR has a Current Ratio of 2.37. This indicates that CPR is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 2.37, CPR belongs to the best of the industry, outperforming 88.89% of the companies in the same industry.
CPR has a Quick Ratio of 2.37. This is a bad value and indicates that CPR is not financially healthy enough and could expect problems in meeting its short term obligations.
CPR has a Quick ratio of 0.99. This is amongst the best in the industry. CPR outperforms 81.48% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.37 | ||
| Quick Ratio | 0.99 |
3. Growth
3.1 Past
CPR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -40.50%.
Measured over the past years, CPR shows a decrease in Earnings Per Share. The EPS has been decreasing by -8.12% on average per year.
The Revenue has been growing slightly by 5.18% in the past year.
Measured over the past years, CPR shows a quite strong growth in Revenue. The Revenue has been growing by 10.75% on average per year.
EPS 1Y (TTM)-40.5%
EPS 3Y-11.44%
EPS 5Y-8.12%
EPS Q2Q%N/A
Revenue 1Y (TTM)5.18%
Revenue growth 3Y12.21%
Revenue growth 5Y10.75%
Sales Q2Q%N/A
3.2 Future
CPR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.19% yearly.
The Revenue is expected to grow by 4.55% on average over the next years.
EPS Next Y-0.75%
EPS Next 2Y4.05%
EPS Next 3Y6.7%
EPS Next 5Y11.19%
Revenue Next Year2.33%
Revenue Next 2Y2.67%
Revenue Next 3Y3.66%
Revenue Next 5Y4.55%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 35.05, which means the current valuation is very expensive for CPR.
Based on the Price/Earnings ratio, CPR is valued a bit more expensive than the industry average as 74.07% of the companies are valued more cheaply.
The average S&P500 Price/Earnings ratio is at 26.03. CPR is valued slightly more expensive when compared to this.
With a Price/Forward Earnings ratio of 18.54, CPR is valued on the expensive side.
CPR's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 22.27. CPR is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 35.05 | ||
| Fwd PE | 18.54 |
4.2 Price Multiples
CPR's Enterprise Value to EBITDA ratio is in line with the industry average.
Based on the Price/Free Cash Flow ratio, CPR is valued a bit more expensive than 66.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 34.87 | ||
| EV/EBITDA | 12.88 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y4.05%
EPS Next 3Y6.7%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 1.08%, CPR has a reasonable but not impressive dividend return.
CPR's Dividend Yield is slightly below the industry average, which is at 2.81.
Compared to an average S&P500 Dividend Yield of 2.38, CPR's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.08% |
5.2 History
The dividend of CPR decreases each year by -2.80%.
Dividend Growth(5Y)-2.8%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
38.74% of the earnings are spent on dividend by CPR. This is a low number and sustainable payout ratio.
DP38.74%
EPS Next 2Y4.05%
EPS Next 3Y6.7%
BIT:CPR (11/4/2025, 7:00:00 PM)
5.958
+0.07 (+1.19%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)
Earnings (Next)
Inst Owners22.94%
Inst Owner ChangeN/A
Ins Owners51.06%
Ins Owner ChangeN/A
Market Cap7.34B
Revenue(TTM)3.07B
Net Income(TTM)201.60M
Analysts70.77
Price Target6.88 (15.47%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.08% |
Yearly Dividend0.04
Dividend Growth(5Y)-2.8%
DP38.74%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.54%
PT rev (3m)-0.39%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-2.03%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.48%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 35.05 | ||
| Fwd PE | 18.54 | ||
| P/S | 2.39 | ||
| P/FCF | 34.87 | ||
| P/OCF | 10.94 | ||
| P/B | 1.9 | ||
| P/tB | 160.88 | ||
| EV/EBITDA | 12.88 |
EPS(TTM)0.17
EY2.85%
EPS(NY)0.32
Fwd EY5.39%
FCF(TTM)0.17
FCFY2.87%
OCF(TTM)0.54
OCFY9.14%
SpS2.49
BVpS3.13
TBVpS0.04
PEG (NY)N/A
PEG (5Y)N/A
Graham Number3.46
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.38% | ||
| ROE | 5.23% | ||
| ROCE | 9.04% | ||
| ROIC | 6.63% | ||
| ROICexc | 6.65% | ||
| ROICexgc | 14.09% | ||
| OM | 21.32% | ||
| PM (TTM) | 6.57% | ||
| GM | 57.55% | ||
| FCFM | 6.85% |
ROA(3y)4.29%
ROA(5y)4.52%
ROE(3y)9.66%
ROE(5y)10.08%
ROIC(3y)7.66%
ROIC(5y)7.27%
ROICexc(3y)8.52%
ROICexc(5y)8.34%
ROICexgc(3y)23.37%
ROICexgc(5y)25.9%
ROCE(3y)10.45%
ROCE(5y)9.91%
ROICexgc growth 3Y-20.45%
ROICexgc growth 5Y-21.73%
ROICexc growth 3Y-7.67%
ROICexc growth 5Y-5.91%
OM growth 3Y3.05%
OM growth 5Y-0.43%
PM growth 3Y-20.58%
PM growth 5Y-17.07%
GM growth 3Y-1.21%
GM growth 5Y-1.11%
F-Score4
Asset Turnover0.36
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.66 | ||
| Debt/FCF | 13.61 | ||
| Debt/EBITDA | 3.27 | ||
| Cap/Depr | 360.3% | ||
| Cap/Sales | 14.99% | ||
| Interest Coverage | 6.99 | ||
| Cash Conversion | 85.71% | ||
| Profit Quality | 104.37% | ||
| Current Ratio | 2.37 | ||
| Quick Ratio | 0.99 | ||
| Altman-Z | 2.43 |
F-Score4
WACC6.77%
ROIC/WACC0.98
Cap/Depr(3y)346.34%
Cap/Depr(5y)266.11%
Cap/Sales(3y)12.99%
Cap/Sales(5y)10.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-40.5%
EPS 3Y-11.44%
EPS 5Y-8.12%
EPS Q2Q%N/A
EPS Next Y-0.75%
EPS Next 2Y4.05%
EPS Next 3Y6.7%
EPS Next 5Y11.19%
Revenue 1Y (TTM)5.18%
Revenue growth 3Y12.21%
Revenue growth 5Y10.75%
Sales Q2Q%N/A
Revenue Next Year2.33%
Revenue Next 2Y2.67%
Revenue Next 3Y3.66%
Revenue Next 5Y4.55%
EBIT growth 1Y6.42%
EBIT growth 3Y15.63%
EBIT growth 5Y10.27%
EBIT Next Year24.36%
EBIT Next 3Y12.31%
EBIT Next 5Y10.13%
FCF growth 1Y232.49%
FCF growth 3Y-14.61%
FCF growth 5Y-4.94%
OCF growth 1Y328.44%
OCF growth 3Y11.5%
OCF growth 5Y13.06%
DAVIDE CAMPARI-MILANO NV / CPR.MI FAQ
Can you provide the ChartMill fundamental rating for DAVIDE CAMPARI-MILANO NV?
ChartMill assigns a fundamental rating of 4 / 10 to CPR.MI.
What is the valuation status of DAVIDE CAMPARI-MILANO NV (CPR.MI) stock?
ChartMill assigns a valuation rating of 1 / 10 to DAVIDE CAMPARI-MILANO NV (CPR.MI). This can be considered as Overvalued.
What is the profitability of CPR stock?
DAVIDE CAMPARI-MILANO NV (CPR.MI) has a profitability rating of 5 / 10.
What is the valuation of DAVIDE CAMPARI-MILANO NV based on its PE and PB ratios?
The Price/Earnings (PE) ratio for DAVIDE CAMPARI-MILANO NV (CPR.MI) is 35.05 and the Price/Book (PB) ratio is 1.9.
How sustainable is the dividend of DAVIDE CAMPARI-MILANO NV (CPR.MI) stock?
The dividend rating of DAVIDE CAMPARI-MILANO NV (CPR.MI) is 2 / 10 and the dividend payout ratio is 38.74%.